Prolific Machines

Illuminating biomanufacturing. Enabling tomorrow’s biotherapeutics

A flexible, next-generation Cell Line Development Platform for your biotherapeutics.

Our Photomolecular™ platform integrates advanced Optogenetic Cell Line Development technology with AI-driven bioprocess optimization for dynamic, tunable cellular control. By using light, we boost titers by up to 5-fold and unlock the production of difficult-to-express biotherapeutics, while also improving quality and consistency. Designed for flexibility and scalability, our solutions adapt to your manufacturing context, with expert collaboration and technical support at every step.

A new infrastructure layer for biology.

Off
On

Custom solutions: Our light control and genetic constructs interact directly with your biology.

We can precisely control any cellular function in any cell type by activating photosensitive receptors. When met with the right wavelength of light, these protein switches come together.

Our technology solves developability and COGS challenges in biotherapeutics production.

Prolific approach

Standard approach

Decouple cell growth from protein production

We enable cells to focus their resources entirely on either maximizing growth or production. In the dark, expression is suppressed, improving cell viability, density, and reducing cell stress. By switching on the light, expression of the target gene is induced, driving higher titers.

Prolific approach

Maximize titer and quality by tuning expression

We can precisely control target gene expression with light to improve titers and maintain cell health. By modulating expression, we can ensure that the cell’s protein processing capabilities are matched with the production rate controlled by light, for example, due to secretory bottlenecks or protein toxicity, expression levels can be reduced, allowing the cell to recover and continue producing high-quality protein.

Prolific approach

Control Post-Translational Modifications to match desired CQAs

We can precisely tune and titrate genes influencing post-translational modifications, enabling the matching of desired critical quality attributes.

Custom Solutions. Multiple Possibilities.

Do you have a biotherapeutic protein with titer, developability, or COGS challenges? Contact us for a discovery meeting.

Partner with Prolific

Recent News

FAQs

Our Photomolecular platform brings together optogenetic cell line development technology, illumination systems, and AI driven bioprocess optimization to precisely control and optimize cellular behavior to more efficiently produce superior biotherapeutics.

Methods currently used to make biotherapeutics are limited to imprecise, inefficient, and expensive control levers, like temperature, chemicals, and proteins to indirectly control cells. Prolific’s platform brings together safe and effective tools to unlock unparalleled, direct control, and precision.